Dapagliflozin With or Without Spironolactone for HFpEF

Clinical trial NCT05676684 · COMPLETED

Trial details

NCT number: NCT05676684
Sponsor: Universidade do Porto
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Heart Failure With Preserved Ejection Fraction

Start date: 2022-09-15
Primary completion: 2024-11-29
Enrollment: 108

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.